A January 2026 review of topical hormonal acne treatments confirms one prescription option for teens and leaves the rest experimental. The findings do not replace standard combination care for teens with inflammatory acne. Topical hormonal treatments are creams, gels, or solutions that block androgen signals in the skin. Androgens drive oil production and clogged pores, which feed red, painful inflammatory breakouts.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 review covered
- What clascoterone can and cannot do
- Why topical spironolactone is not ready
- What teens with inflammatory acne should do now
What the 2026 review covered
The review surveyed topical hormonal therapies, with focus on clascoterone and topical spironolactone. According to the Journal of Clinical and Aesthetic Dermatology, the authors searched PubMed for topical, antiandrogen, hormonal, clascoterone, spironolactone and acne vulgaris review of topical hormonal therapies. The review also noted one small topical flutamide trial.
Total evidence for compounded options was thin and mixed. The review was funded by Sun Pharma, with authors disclosing consulting and speaker roles. That backing does not invalidate the data, but it favors cautious reading.
What clascoterone can and cannot do
Clascoterone 1% cream blocks dihydrotestosterone at skin androgen receptors. It converts quickly to inactive cortexolone, so effects stay largely local. According to DermNet, the cream gained FDA approval in August 2020 for acne vulgaris in patients 12 years and older, based on two Phase III trials in 1,440 patients plus extension studies DermNet clascoterone overview.
Main side effects are redness, dryness, and irritation. It can be used in males and females. Pooled Phase III results showed twice-daily use improved Investigator's Global Assessment success versus vehicle and cut inflammatory and noninflammatory lesions. Success rates were about 18-20% versus 6-9% for vehicle, so most users still had acne.
Why topical spironolactone is not ready
Topical spironolactone evidence covers only six mostly small trials with about 193 treated patients. Formulas varied across 5% cream or gel, 2% solution, and 1% nanogel, and results conflicted. Neither topical spironolactone nor topical flutamide is FDA-approved.
Both need pharmacy compounding, with no supporting pharmacokinetic data, unlike manufactured clascoterone cream. Studied patients ranged from age 11 to 40 years but were mostly women. That mix limits direct use for teenage boys and for teens whose acne is mainly inflammatory papules, pustules, and nodules.
What teens with inflammatory acne should do now
Standard care still centers on benzoyl peroxide, topical retinoids, topical antibiotics, and fixed-dose combinations. Oral doxycycline and isotretinoin for severe disease retain strong roles, while topical clascoterone holds only a conditional place, according to Dermatology Times reporting on AAD guidelines AAD acne guideline report.
For daily care, keep a combination approach that hits several causes at once and limits long antibiotic courses. Add clascoterone only as an extra, where cost and access allow. Bring the full product list to the visit and ask whether clascoterone fits beside the retinoid and benzoyl peroxide.
- Keep retinoid plus benzoyl peroxide as the base unless a clinician changes it
- Use oral antibiotics short-term and paired with benzoyl peroxide, not alone
- Ask about clascoterone as add-on for oily, androgen-driven areas
- Track redness, peeling, and lesion counts for 8-12 weeks before judging benefit
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: Who Was Studied and Who Was Not for Teens With Inflammatory Acne
- Limited Topical Spironolactone Evidence in the 2026 Review: Who Was Studied and Who Was Not for Teens With Inflammatory Acne
- Adult Female Acne Antiandrogen Treatments in a 2026 Review: Who Was Studied and Who Was Not for Teens With Inflammatory Acne